Why has NICE said this?
NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.
Canagliflozin, dapagliflozin and empagliflozin were recommended because the benefits to patients justify their costs in those who cannot take metformin, and when pioglitazone or sulfonylureas are not the right choices of treatment.